Target intelligence / Profile preview

Zinc transporter 3 (ZnT3 (SLC30A3))

Target
ZnT3 (SLC30A3)
Molecular classification
Transporter, Solute carrier family, Zinc transporter
01

Overview

Zinc transporter 3 (ZnT3; SLC30A3) is a membrane protein of the solute carrier 30 family responsible for transporting zinc from the cytosol into synaptic vesicles and lysosomes, thereby reducing cytoplasmic free zinc concentrations and maintaining zinc homeostasis, especially in the brain[1][2][3]. It is highly expressed in neurons, particularly in the brain where it enables zinc accumulation in synaptic vesicles, and plays a crucial role in synaptic transmission and neurological function[1][3][5]. ZnT3 functions as a probable proton-coupled zinc antiporter, supporting zinc sequestration into intracellular organelles in exchange for protons[3]. Dysregulation or knockout of ZnT3 significantly impairs zinc storage in synaptic vesicles and may be implicated in conditions such as epilepsy and neurodegenerative diseases[3][4][5]. While it is experimentally valuable, drugs specifically targeting ZnT3 are not clinically established and direct pharmacological modulation is not reported in the literature as of yet.

Other names
SLC30A3ZnT3Solute carrier family 30 member 3Zinc transporter ZnT-3Probable proton-coupled zinc antiporter SLC30A3Zinc transporter 3ZNT3ZnT-3
02

Mechanism of action

Zinc ion antiport against protons (proton-coupled zinc transport)

03

Biological functions

Zinc ion transmembrane transportZinc ion import into lysosomeRegulation of cellular zinc ion homeostasisTransport of zinc into synaptic vesiclesMaintenance of cytosolic and vesicular zinc balance in neurons
04

Disease associations

Neurodegenerative diseaseEpilepsyPotentially involved in other neurological disorders
05

Safety considerations

Depletion or mutation leads to loss of synaptic zinc, which may affect synaptic function and neurodevelopmentSystemic modulation could disrupt essential zinc homeostasis in the brain and other tissues
06

Biomarkers

Expression in brain and synaptic vesicles for studies of zinc-associated neuropathology

Beyond the preview

Go deeper on Zinc transporter 3 (ZnT3 (SLC30A3)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc transporter 3 (ZnT3 (SLC30A3)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call